Firy Inc. vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Firy Inc. trades at $12.02 (market cap $199.80M), while Nuvation Bio Inc. Class A Common Stock trades at $4.99 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 8.7× Firy Inc.'s market cap, and Firy Inc. is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| FIRY | NUVB | |
|---|---|---|
Market Cap | $199.80M | $1.74B |
Volume | 92,993 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $13.10 | $9.54 |
52-Week Low | $2.28 | $3.41 |
Typical Hold Time | 13 Days | 1 Days |
Enterprise Value | $168.40M | $1.33B |
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $12.18, up 2.78% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $31.0 million but missed EPS expectations with a net loss. Despite a high gross margin of 87.76%, profitability remains challenged with negative net income margin and ROE. Recent developments include a $719 million legal victory and board appointment of Marc Lasry.
The outlook remains cautious due to persistent cash burn and negative earnings, though the legal win provides potential upside. Investment opportunity hinges on successful monetization of legal claims and operational turnaround. Key risks include ongoing cash flow deficits, competitive pressures, and uncertainty around debt collection from Papaya Gaming.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →